Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0086764 TGF- Inhibitors
Disclosed are pyrazole compounds, as well as pharmaceutical compositions and methods of use thereof. One embodiment is a compound having the structure and...
2018/0086763 BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE CARRYING ARYL- OR HETEROARYLNITRIL GROUPS FOR ORGANIC LIGHT EMITTING DIODES
Novel benzimidazolo[1,2-a]benzimidazoles carrying aryl- or heteroarylnitril groups, an electronic device, comprising said novel ...
2018/0086762 BETA-LACTAMASE INHIBITORS
This invention pertains generally to compounds of Formula (A), ##STR00001## as further described herein, which act as beta-lactamase inhibitors, and salts,...
2018/0086761 NOVEL HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS
The present invention relates to heterocyclic compounds, their process of preparation, pharmaceutical compositions comprising these compounds and use thereof,...
2018/0086760 HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS
The present invention relates to heterocyclic compounds, their process of preparation, pharmaceutical compositions comprising these compounds and use thereof,...
2018/0086759 KEY INTERMEDIATES AND IMPURITIES OF THE SYNTHESIS OF APIXABAN: APIXABAN GLYCOL ESTERS
Object of the present invention is an improved process for the preparation of Apixaban, through new intermediates which undergo to a faster amidation reaction....
2018/0086758 SUBSTITUTED N-(lH-INDAZOL-4-YL)IMIDAZO[l,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE...
Compounds of Formula I: ##STR00001## and pharmaceutically acceptable salts thereof in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 have the...
2018/0086757 TRIAZOLOPYRIDINE COMPOUNDS AND METHODS OF USE THEREOF
Provided are triazolopyridine compounds that are inhibitors of JAK kinase, such as JAK1, compositions containing these compounds and methods for treating...
2018/0086756 SUBSTITUTED TETRAHYDROPYRANS AS CCR2 MODULATORS
Compounds are provided that are modulators of the CCR2 receptor. The compounds have the general formula (I): ##STR00001## and are useful in pharmaceutical...
2018/0086755 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS
This application relates generally to toll like receptor modulator compounds and pharmaceutical compositions which, among other things, modulate toll-like...
2018/0086754 3-(1H-BENZO[D]IMIDAZOL-2-YL)-1H-PYRAZOLO[3,4-C]PYRIDINE AND THERAPEUTIC USES THEREOF
Azaindazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an azaindazole...
2018/0086753 FUSED-TRICYCLIC INHIBITORS OF KRAS AND METHODS OF USE THEREOF
Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I):(I) or a pharmaceutically...
2018/0086752 COMPOSITIONS AND METHODS OF TARGETING MUTANT K-RAS
Compounds and compositions are presented that inhibit K-ras, and especially mutant K-ras. Certain compounds preferentially or even selectively inhibit specific...
2018/0086751 SWEETENER COMPOSITION
Formulations comprising one or more sweetener and one or more flavor modifying compound are provided herein, wherein the formulation is provided for use in...
2018/0086750 NOVEL HISTONE DEACETYLASE INHIBITORS AND THEIR USE IN THERAPY
A compound of the formula: (I) or a pharmaceutically acceptable salt thereof, wherein: L is a 5-membered nitrogen-containing heteroaryl which is optionally...
2018/0086749 INHIBITORS OF VIRUSES
The present technology is directed to compounds, compositions, and methods to treat a viral infection. The compound is according to Formula I or a solvate...
2018/0086748 HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS
The present invention encompasses compounds of the formula (I) ##STR00001## wherein the groups A, Cy, X1 and Y are defined herein, which are suitable for the...
2018/0086747 PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS
The present application provides the compounds of formula I or IA ##STR00001## or pharmaceutically acceptable salts, isomers, tautomer, or a mixture thereof,...
2018/0086746 HETEROATOM CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS
Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions in a method of treating...
2018/0086745 POLYCYCLIC INHIBITOR OF ANAPLASTIC LYMPHOMA KINASE
Disclosed is a polycyclic inhibitor of anaplastic lymphoma kinase as represented by Formula (I), or a pharmaceutically acceptable salt or stereoisomer thereof....
2018/0086744 COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS
The invention relates to a therapy of cancer comprising co-administration to a person in need of such treatment and/or co-treatment of a person in need of such...
2018/0086742 SUBSTITUTED OXOPYRIDINE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF CARDIOVASCULAR DISORDERS
The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the...
2018/0086741 KINASE INHIBITORS
There are provided compounds of formula (III), ##STR00001## or a salt or protected derivative thereof, wherein Z.sup.2 represents a structural fragment of...
2018/0086740 BIOCIDAL COATINGS AND METHODS FOR MAKING SAME
Methods for increasing biocidal activity of a substrate are provided. The methods can include attaching one or more ionic compounds to the substrate. The ionic...
2018/0086739 PLK4 INHIBITORS
Provided herein, inter alia, are compounds and methods for inhibiting PLK4 and for treating cancer in a subject in need thereof.
2018/0086738 PYRAZOLE COMPOUNDS OR SALTS THEREOF, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF
Disclosed are a pyrazole compound or a salt thereof, a preparation method therefor, a herbicidal composition and use thereof. The pyrazole compound or a salt...
2018/0086737 INDAZOLONES AS MODULATORS OF TNF SIGNALING
The disclosure provides indazolone compounds, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof...
2018/0086736 RORC2 INHIBITORS AND METHODS OF USE THEREOF
The present invention provides compounds, pharmaceutical compositions, methods of inhibiting ROR.gamma. activity and/or reducing the amount of IL-17 in a...
2018/0086735 N-CYCLOALKYL-N-(BIHETEROCYCLYETHYLENE)-(THIO)CARBOXAMIDE DERIVATIVES
The present invention relates to fungicidal N-cycloalkyl-N-(biheterocyclylethylene)carboxamide derivatives and their thiocarbonyl derivatives, their process of...
2018/0086734 MODIFIED AMINO ACIDS COMPRISING TETRAZINE FUNCTIONAL GROUPS, METHODS OF PREPARATION, AND METHODS OF THEIR USE
Provided herein are modified amino acids comprising a tetrazine groups according to Formula I: polypeptides, antibodies, payloads and conjugates comprising...
2018/0086733 PYRIDINYL QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS
The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation...
2018/0086732 GHRELIN 0-ACYL TRANSFERASE INHIBITORS
The present invention provides novel GOAT inhibitors and their salts and pharmaceutical compositions thereof.
2018/0086731 CRYSTALLINE FORMS OF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYAN- ...
This invention relates to a crystalline form of 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyan- ophenyl)urea maleate, and to...
2018/0086730 TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME
Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary...
2018/0086729 FLAVAGLINE DERIVATIVES
The invention relates to compounds of the following general formula (I) in the form of one of the enantiomers thereof or a mixture of the enantiomers thereof,...
2018/0086728 Method of producing furan carboxylates from aldaric acids by using solid heterogeneous catalyst
According to an example aspect of the present invention, there is provided a method of producing furan carboxylates from aldaric acids in the presence of a...
2018/0086727 NEUROACTIVE SUBSTITUTED CYCLOPENT[a]ANTHRACENES AS MODULATORS FOR GABA TYPE-A RECEPTORS
The present disclosure is generally directed to neuroactive substituted cyclopent[a]anthracenes as referenced herein, and pharmaceutically acceptable salts...
2018/0086726 1,3,4-Oxadiazole and 1,3,4-Thiadiazole Derivatives as Immunomodulators
The present invention relates to synthetic methods for 1,3,4-oxadiazole and 1,3,4-thiadiazole compounds. The general synthetic scheme is: ##STR00001## R.sub.1...
2018/0086725 Alignment Compounds
The present invention relates to compounds represented by the following Formula (I). With reference to Formula (I), at least one of E.sup.1 and E.sup.2...
2018/0086724 HETEROBIFUNCTIONAL LINKER
The present disclosure relates generally to heterobifunctional linkers.
2018/0086723 TREATMENT OF PULMONARY AND OTHER CONDITIONS
Disclosed is a compound, or a pharmaceutically acceptable salt or ester thereof, having a structure of: X.sup.1-L-X.sup.2 wherein L is a linking moiety...
2018/0086722 PROCESSES FOR THE PREPARATION OF PYRIMIDINYLCYCLOPENTANE COMPOUNDS
The present invention relates to a process for the preparation of a compound of formula (I) ##STR00001## wherein R.sup.1 is as defined herein, which is useful...
2018/0086721 MORPHIC FORMS OF HEXADECYLOXYPROPYL-PHOSPHONATE ESTERS AND METHODS OF SYNTHESIS THEREOF
The disclosure describes methods of synthesis of phosphonate ester compounds. The methods according to the disclosure allow for large-scale preparation of...
2018/0086720 THERAPEUTIC COMPOUNDS AND USES THEREOF
The present invention relates to compounds of formula (I): ##STR00001## and salts thereof, wherein: R.sup.1-R.sup.4 have any of the values defined in the...
2018/0086719 PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS
The present application provides the compounds of formula I ##STR00001## or pharmaceutically acceptable salts, isomers, tautomer, or a mixture thereof, wherein...
2018/0086718 Diarylhydantoin Compounds
The present invention relates to diarylhydantoin compounds, including diarylthiohydantoins, and methods for synthesizing them and using them in the treatment...
2018/0086717 HYDROGEN BARRIER AGENT, HYDROGEN BARRIER FILM FORMING COMPOSITION, HYDROGEN BARRIER FILM, METHOD FOR PRODUCING...
To provide a hydrogen barrier agent capable of imparting hydrogen barrier performance to various materials; a hydrogen barrier film forming composition...
2018/0086716 Indazole Compounds for Use in Tendon and/or Ligament Injuries
The present invention provides a compound of formula (I) in free form or in pharmaceutically acceptable salt form ##STR00001## a method for manufacturing the...
2018/0086715 PROCESS FOR PREPARING PYRAZOLES
The present invention relates to a process for preparing a pyrazole compound of formula V, the process including cyclizing a hydrazone substituted...
2018/0086714 Quinoline Compounds
The present invention relates to compounds I ##STR00001## wherein the variables are defined as given in the description and claims. The invention further relates...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.